We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Actavis to Buy Allergan for $66B In Latest ‘Transformative Deal’
Actavis to Buy Allergan for $66B In Latest ‘Transformative Deal’
Specialty and generic drug maker Actavis has agreed to buy botox manufacturer Allergan for $66 billion in a move analysts say could help transform Actavis into a major pharma giant.